Dr. Maytin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-444-2200Fax+1 216-444-9198
Education & Training
Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1986 - 1990
Rhode Island Hospital/Brown University HealthInternship, Internal Medicine, 1985 - 1986
University of Rochester School of Medicine and DentistryClass of 1985
Certifications & Licensure
CA State Medical License 1990 - Present
OH State Medical License 2000 - 2026
MA State Medical License 1990 - 2011
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer Start of enrollment: 2008 Mar 01
- Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses Start of enrollment: 2014 Apr 01
- Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome Start of enrollment: 2016 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model.Pushpamali De Silva, Mohammad A Saad, Joseph W R Swain, Zhiming Mai, Madeline D Kidd
Journal of Photochemistry and Photobiology. B, Biology. 2025-04-01 - A Clinical Trial to Determine the Impact of Tumor Size, Histological Subtype, and Vitamin D Status on the Therapeutic Response of Basal Cell Carcinoma to Photodynamic ...Edward V Maytin, Nathalie C Zeitouni, Abigail Updyke, Jeffrey Negrey, Alan S Shen
Medrxiv. 2025-02-03 - 1 citationsTreatment of nonmelanoma skin cancer with pro-differentiation agents and photodynamic therapy: Preclinical and clinical studies (Review).Sanjay Anand, Tayyaba Hasan, Edward V Maytin
Photochemistry and Photobiology. 2024-02-04
Press Mentions
Dermatologists Combine Two Effective Treatments for Precancerous Actinic KeratosesSeptember 13th, 2018
Expanding Our Options for Treating Actinic KeratosesJanuary 26th, 2021
Grant Support
- Photodynamic Priming of Cancer and Image-guidance for Optimal Immune ResponseMASSACHUSETTS GENERAL HOSPITAL1999–2027
- Photodynamic Priming of Cancer and Image-guidance for Optimal Immune ResponseMASSACHUSETTS GENERAL HOSPITAL1999–2027
- Hyaluronan (HA) As A Regulator Of Inflammation And FibrosisNational Heart, Lung, And Blood Institute2011
- Combination Therapy With 5-FU And PDT For The Treatment Of Post-Transplant PremalNational Cancer Institute2011
- Hyaluronan In Epidermal Injury ResponsesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009
- Hyaluronan And Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2007
- C/Edb Beta And CHOP In Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2002
- C/Edb Beta And CHOP In Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–1999
- Regulation Of The K10 Gene By C/Ebps In KeratinocytesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1995–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
